Sasko Kedev Selected Research

Hemorrhage

1/2021	Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
10/2020	Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention.
10/2019	Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial.
4/2019	Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study.
1/2018	Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study.
1/2018	Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
1/2018	Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.
1/2018	Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score.
1/2018	Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
10/2016	BleeMACS: rationale and design of the study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sasko Kedev Research Topics

Disease

27	ST Elevation Myocardial Infarction 11/2022 - 08/2014
20	Acute Coronary Syndrome 11/2022 - 08/2013
16	Hemorrhage 01/2021 - 08/2013
14	Myocardial Infarction 11/2021 - 08/2014
11	Stroke (Strokes) 01/2021 - 09/2014
11	Thrombosis (Thrombus) 01/2021 - 02/2013
8	Heart Failure 11/2022 - 04/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2014
5	Infarction (Infarctions) 01/2020 - 03/2016
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2018
3	Hypertension (High Blood Pressure) 10/2020 - 01/2018
3	Neoplasms (Cancer) 10/2018 - 02/2017
2	Ischemia 11/2021 - 09/2016
2	Hypercholesterolemia 04/2021 - 10/2020
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2019
2	Pathologic Constriction (Stenosis) 12/2019 - 01/2018
2	Ischemic Stroke 01/2019 - 12/2015
2	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2014
2	Cardiogenic Shock 08/2015 - 04/2015
1	Heart Diseases (Heart Disease) 11/2022
1	Carotid Stenosis (Carotid Artery Stenosis) 03/2022
1	Arteriovenous Fistula 01/2022
1	Death (Near-Death Experience) 11/2021
1	Transient Ischemic Attack 01/2020
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2019
1	Pain (Aches) 01/2019
1	Unstable Angina 01/2019
1	Diabetes Mellitus 01/2018
1	Atherosclerosis 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Stable Angina 01/2018
1	Non-ST Elevated Myocardial Infarction 07/2017
1	Pulmonary Embolism 07/2017
1	Thrombocytopenia (Thrombopenia) 07/2017
1	Left Ventricular Dysfunction 03/2016
1	Chronic Renal Insufficiency 01/2016
1	Chest Pain (Chest Pains) 12/2015
1	Spasm (Spasms) 01/2014
1	Peripheral Arterial Disease 01/2013

Drug/Important Bio-Agent (IBA)

6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022 - 02/2017
6	omega-Chloroacetophenone (Mace)IBA 11/2021 - 09/2014
5	Clopidogrel (Plavix)FDA Link 10/2019 - 07/2015
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2021 - 01/2018
3	MetalsIBA 01/2021 - 12/2017
3	TicagrelorIBA 10/2019 - 03/2016
3	Proton Pump InhibitorsIBA 10/2018 - 03/2016
3	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 07/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 02/2020 - 10/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2020 - 10/2018
2	AnticoagulantsIBA 01/2020 - 12/2015
1	Digoxin (Digitek)FDA LinkGeneric 11/2022
1	Triglycerides (Triacylglycerol)IBA 04/2021
1	Prasugrel Hydrochloride FDA Link 10/2019
1	PolymersIBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 04/2019
1	alirocumabIBA 01/2019
1	Biological ProductsIBA 10/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018
1	CreatinineIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2018
1	Troleandomycin (TAO)FDA Link 01/2018
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2018
1	PCSK9 InhibitorsIBA 01/2018
1	Eptifibatide (Integrilin)FDA Link 01/2018
1	AdipokinesIBA 01/2018
1	otamixabanIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Fibric Acids (Fibrates)IBA 01/2018
1	A-factor (Streptomyces)IBA 08/2017
1	gossypol acetic acidIBA 08/2017
1	TroponinIBA 08/2017
1	Pharmaceutical PreparationsIBA 07/2017
1	RivaroxabanIBA 07/2017
1	Protective AgentsIBA 02/2017
1	Enoxaparin (Lovenox)FDA LinkGeneric 07/2015
1	Sodium Glutamate (Accent)IBA 01/2013

Therapy/Procedure

34	Percutaneous Coronary Intervention 01/2021 - 02/2013
21	Therapeutics 11/2022 - 08/2013
9	Thrombectomy 01/2020 - 04/2015
8	Stents 03/2022 - 04/2015
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2018
3	Drug-Eluting Stents 01/2021 - 12/2017
3	Blood Transfusion (Blood Transfusions) 01/2018 - 10/2016
2	Punctures 01/2019 - 01/2014
1	Renal Dialysis (Hemodialysis) 01/2022
1	Transcatheter Aortic Valve Replacement 10/2019
1	Contraindications 01/2018
1	Thrombolytic Therapy 12/2015